EyePoint Pharmaceuticals, Inc. (EYPT) Social Stream
EyePoint Pharmaceuticals Inc (EYPT) Price Targets From Analysts
Use the tables below to see what analysts covering EyePoint Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 30 weeks, EYPT's average price target has gone up $10.92.
Over the past 47 weeks, EYPT's average upside potential has been 110.17%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
EYPT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
EYPT's average broker recommendation rating improved by 1 over the prior 30 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- EyePoint Pharmaceuticals Inc's number of analysts covering the stock is greater than 38.13% of all US stocks.
- EYPT has a greater average analyst price target than 69.52% of Measuring and Control Equipment stocks.
- EYPT has a higher upside potential (average analyst target price relative to current price) than 323.36% of Measuring and Control Equipment stocks.
- In the context of Measuring and Control Equipment stocks, EyePoint Pharmaceuticals Inc's variance in analysts' estimates is lower than -174.92% of them.
In the Measuring and Control Equipment industry, DNAY, AXDX, and CYBE are the three stocks most similar to EyePoint Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding EYPT using the data that counts. Try POWR Ratings for free.